Related Experiment Video
Updated: Mar 11, 2026

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
Designed covalent allosteric modulators: an emerging paradigm in drug discovery
1Department of Pathophysiology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.
Covalent allosteric modulators combine benefits of covalent and allosteric drugs, offering high potency and specificity. This review highlights successful examples and future directions for these valuable drug discovery tools.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Drug Discovery
Background:
- Covalent ligands offer high potency and prolonged action but can lack specificity.
- Allosteric modulators provide enhanced specificity and reduced toxicity.
- Covalent allosteric modulators merge these advantages, emerging as a significant strategy in drug discovery.
Purpose of the Study:
- To review recent advancements in the design of covalent allosteric modulators.
- To highlight successful applications and examples of this therapeutic approach.
- To discuss current challenges and future prospects in the field.
Main Methods:
- Literature review of scientific publications and patents.
- Analysis of successful case studies in covalent allosteric modulator development.
- Synthesis of information on target proteins and design strategies.
Main Results:
- Covalent allosteric modulators demonstrate significant pharmacological advantages, including high potency, extended duration, low drug resistance, and improved specificity.
- A wide range of protein targets are amenable to modulation by this strategy, underscoring its broad applicability.
- Numerous successful examples illustrate the efficacy and potential of covalent allosteric modulators.
Conclusions:
- Covalent allosteric modulators represent a powerful and increasingly recognized approach in modern drug discovery.
- Continued research and development are expected to overcome existing challenges and unlock further therapeutic potential.
- This strategy holds promise for developing novel therapeutics with improved pharmacological profiles.
Related Concept Videos
Cooperative Allosteric Transitions
Cooperative Allosteric Transitions
Cooperative Allosteric Transitions
Allosteric Regulation
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Ligand Binding and Linkage

